Author: admin

  • Andrew Gwynne – 2016 Parliamentary Question to the Department of Health

    Andrew Gwynne – 2016 Parliamentary Question to the Department of Health

    The below Parliamentary question was asked by Andrew Gwynne on 2016-05-24.

    To ask the Secretary of State for Health, what recent guidance his Department published to commissioners on meeting excess treatment costs for clinical trials.

    George Freeman

    In November 2015, NHS England published new guidance to help clarify the rules and expectations on the funding of excess treatment costs incurred during a non-commercial research study. The guidance is provided for clinical commissioning groups and commissioners of specialised services.

  • Chris Green – 2016 Parliamentary Question to the Department of Health

    Chris Green – 2016 Parliamentary Question to the Department of Health

    The below Parliamentary question was asked by Chris Green on 2016-05-24.

    To ask the Secretary of State for Health, what estimate he has made of the effect of antimicrobial resistance on hospital budgets.

    Jane Ellison

    The current cost of antimicrobial resistance to the National Health Service is estimated to be in excess of £180 million per annum.

  • Chris Green – 2016 Parliamentary Question to the Department of Health

    Chris Green – 2016 Parliamentary Question to the Department of Health

    The below Parliamentary question was asked by Chris Green on 2016-05-24.

    To ask the Secretary of State for Health, what estimate his Department has made of the potential number of deaths due to drug-resistant bacteria in the UK in each of the next three years.

    Jane Ellison

    Specific information on the number of deaths attributable to antimicrobial resistance is not currently available.

    However, a Europe wide study of multi-drug resistance1 estimated the number of deaths in the European Union, Norway and Iceland, due to multi-drug resistance in five specific bacteria. On the basis of population size, other things being equal, the conclusions reached in the study would imply that around 3,000 deaths per year in the United Kingdom may be due to multi-drug resistance in those specified infections. This is likely to be an underestimate as it omits consideration of large numbers of other bacteria.

    Note:

    1 European Centre for Disease Prevention and Control/European Medicines Agency Joint Technical Report: The bacterial challenge: time to react 2009

  • Andrew Gwynne – 2016 Parliamentary Question to the Department of Health

    Andrew Gwynne – 2016 Parliamentary Question to the Department of Health

    The below Parliamentary question was asked by Andrew Gwynne on 2016-05-24.

    To ask the Secretary of State for Health, what methodology and data NHS England plans to use to determine which services it will commission at the specialised commissioning prioritisation process in June 2016.

    George Freeman

    The Clinical Priorities Advisory Group (CPAG) will agree recommendations as to which proposals for new investments in specialised services should be considered by NHS England in the prioritisation round for 2016/17. CPAG is scheduled to meet between 6 and 9 June 2016.

    NHS England is currently considering the outcome of a public consultation that it held between April and May 2016 on a proposed method for the relative prioritisation of new investments in specialised services. The consultation guide that it published described the proposed method and the types of data that would be considered. Many detailed submissions were made by respondents to consultation, and they will all be carefully considered. NHS England is expecting to make a decision on the eventual method that will be adopted for 2016/17 in May 2016.

    The consultation guide can be found at the following address:

    https://www.engage.england.nhs.uk/consultation/investment-decisions/supporting_documents/consultationguide.pdf

    “

  • Andrew Gwynne – 2016 Parliamentary Question to the Department of Health

    Andrew Gwynne – 2016 Parliamentary Question to the Department of Health

    The below Parliamentary question was asked by Andrew Gwynne on 2016-05-24.

    To ask the Secretary of State for Health, how many services which have been approved by NHS England’s Clinical Priorities Advisory Group are planned for discussion at the NHS England prioritisation round in June.

    George Freeman

    The Clinical Priorities Advisory Group (CPAG) will agree recommendations as to which proposals for new investments in specialised services should be considered by NHS England in the prioritisation round for 2016/17. CPAG is scheduled to meet between 6 and 9 June 2016.

    NHS England is currently considering the outcome of a public consultation that it held between April and May 2016 on a proposed method for the relative prioritisation of new investments in specialised services. The consultation guide that it published described the proposed method and the types of data that would be considered. Many detailed submissions were made by respondents to consultation, and they will all be carefully considered. NHS England is expecting to make a decision on the eventual method that will be adopted for 2016/17 in May 2016.

    The consultation guide can be found at the following address:

    https://www.engage.england.nhs.uk/consultation/investment-decisions/supporting_documents/consultationguide.pdf

    “

  • Andrew Gwynne – 2016 Parliamentary Question to the Department of Health

    Andrew Gwynne – 2016 Parliamentary Question to the Department of Health

    The below Parliamentary question was asked by Andrew Gwynne on 2016-05-24.

    To ask the Secretary of State for Health, when he plans to publish the equality impact assessment on the proposed HPV vaccination programme for men who have sex with men.

    Jane Ellison

    Public Health England is starting a human papillomavirus (HPV) vaccination pilot for men who have sex with men in June 2016. Information gathered during the pilot will help inform an equality impact assessment for a national programme if the pilot is successful.

  • Andrew Gwynne – 2016 Parliamentary Question to the Department of Health

    Andrew Gwynne – 2016 Parliamentary Question to the Department of Health

    The below Parliamentary question was asked by Andrew Gwynne on 2016-05-24.

    To ask the Secretary of State for Health, whether he plans for the HPV vaccination programme at sexual health clinics for men who have sex with men to be rolled out nationally at the earliest opportunity or to be implemented through initial pilot projects.

    Jane Ellison

    The Joint Committee on Vaccination and Immunisation (JCVI), the expert body that advises the Government on all immunisation matters, advised that a targeted human papillomavirus (HPV) vaccination programme should be undertaken for men who have sex with men (MSM) up to 45 years of age who attend genitourinary medicine and HIV clinics. They noted that this should be subject to procurement of the vaccine and delivery of the programme at a cost-effective price. JCVI acknowledged that finding a way to implement its advice would be challenging and made clear that work was needed by the Department and others to consider commissioning and delivery routes for this programme.

    The Department announced on 26 May 2016 that an HPV vaccination pilot for MSM would start in June.

  • Andrew Gwynne – 2016 Parliamentary Question to the Department of Health

    Andrew Gwynne – 2016 Parliamentary Question to the Department of Health

    The below Parliamentary question was asked by Andrew Gwynne on 2016-05-24.

    To ask the Secretary of State for Health, what the timetable is for implementing HPV vaccinations at sexual health clinics for men who have sex with men.

    Jane Ellison

    The Joint Committee on Vaccination and Immunisation (JCVI), the expert body that advises the Government on all immunisation matters, advised that a targeted human papillomavirus (HPV) vaccination programme should be undertaken for men who have sex with men (MSM) up to 45 years of age who attend genitourinary medicine and HIV clinics. They noted that this should be subject to procurement of the vaccine and delivery of the programme at a cost-effective price. JCVI acknowledged that finding a way to implement its advice would be challenging and made clear that work was needed by the Department and others to consider commissioning and delivery routes for this programme.

    The Department announced on 26 May 2016 that an HPV vaccination pilot for MSM would start in June.

  • Steve McCabe – 2016 Parliamentary Question to the Department of Health

    Steve McCabe – 2016 Parliamentary Question to the Department of Health

    The below Parliamentary question was asked by Steve McCabe on 2016-05-24.

    To ask the Secretary of State for Health, with reference to the Answer of 4 May 2016 to Question 36039, on fertility: medical treatments, which criteria set out in the Health and Social Care Act 2012 fertility services do not meet in order to be centrally commissioned.

    Jane Ellison

    The Health and Social Care Act 2012, part 1, Section 15, 3B (3), about services that the Secretary of States can require the Board (NHS England) to commission, states:

    “(3) In deciding whether it would be so appropriate, the Secretary of State must have regard to:

    (a) the number of individuals who require the provision of the service or facility;

    (b) the cost of providing the service or facility;

    (c) the number of persons able to provide the service or facility;

    (d) the financial implications for clinical commissioning groups if they were required to arrange for the provision of the service or facility.”

    The Clinical Advisory Group, which advised Ministers about the services that should be regarded as specialised and commissioned nationally by NHS England, took the view that fertility services would not meet (a) and (c) of these listed factors.

  • Catherine West – 2016 Parliamentary Question to the Department of Health

    Catherine West – 2016 Parliamentary Question to the Department of Health

    The below Parliamentary question was asked by Catherine West on 2016-05-24.

    To ask the Secretary of State for Health, when he plans to make public decisions on HIV pre-exposure prophylaxis taken at the meeting to consider the commissioning specialised services on 31 May 2016.

    Jane Ellison

    NHS England’s Specialised Services Commissioning Committee have considered and accepted NHS England’s external legal advice that it does not have the legal power to commission pre-exposure prophylaxis (PrEP). However, work on PrEP is on-going and up to £2 million will be invested in a pilot programme to target those at highest risk over the course of two years.

    Public Health England is working to identify the most effective locations for the introduction of this pilot. The Department will be discussing future commissioning with stakeholders.

    Our £2.4 million national HIV Prevention and Sexual Health Promotion Programme also gives those at highest risk the best advice to make safer choices about sex.